Andrew Obenshain
Chief Executive Officer presso BLUEBIRD BIO, INC.
Patrimonio netto: 358 397 $ in data 31/03/2024
Posizioni attive di Andrew Obenshain
Società | Posizione | Inizio | Fine |
---|---|---|---|
BLUEBIRD BIO, INC. | Director/Board Member | 04/11/2021 | - |
Chief Executive Officer | 04/11/2021 | - | |
President | 04/11/2021 | - | |
Corporate Officer/Principal | 01/01/2016 | 04/11/2021 | |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Director/Board Member | 30/03/2017 | - |
Storia della carriera di Andrew Obenshain
Precedenti posizioni note di Andrew Obenshain
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Formazione di Andrew Obenshain
Dartmouth College | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Francia | 2 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Aziende private | 2 |
---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
- Borsa valori
- Insiders
- Andrew Obenshain
- Esperienza